ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,110Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 55

$886K Total Retail Price of All Prescriptions

Rank: 1 out of 55

612 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 612 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 612 patients filled at least one prescription for a schedule three drug, compared to an average of 21%.

Risky Drugs to Seniors

4% of this provider’s 11,081 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 702 444 S3 1 1
LEVOTHYROXINE SODIUM 577 465 2 3
OMEPRAZOLE 518 385 3 4
AMLODIPINE BESYLATE 338 249 4 9
LISINOPRIL 331 249 5 2
FUROSEMIDE 292 203 6 5
MELOXICAM 284 235 7 11
METFORMIN HCL 275 205 8 8
TRAMADOL HCL 262 242 9 13
POTASSIUM CHLORIDE 242 186 10 7
GABAPENTIN 238 154 11 10
SIMVASTATIN 232 167 12 6
POLYETHYLENE GLYCOL 3350 230 208 13 33
CITALOPRAM HBR 222 178 14 12
ZOLPIDEM TARTRATE 176 122 15 17
CIPROFLOXACIN HCL 176 133 15 32
PRAVASTATIN SODIUM 170 146 17 25
SERTRALINE HCL 167 101 18 22
ATENOLOL 165 140 19 27
NEXIUM 163 138 20 20
ENALAPRIL MALEATE 159 135 21 68
TRIAMTERENE-HCTZ 159 117 21 91
WARFARIN SODIUM 158 126 23 21
DONEPEZIL HCL 146 146 24 24
CARVEDILOL 133 98 25 35
ATORVASTATIN CALCIUM 133 110 25 19
METOPROLOL TARTRATE 130 100 27 14
CYMBALTA 129 63 28 47
NAMENDA 122 110 29 23
METHYLPREDNISOLONE 120 89 30 93
ESTRADIOL 112 93 R 31 100
HYDROCHLOROTHIAZIDE 110 94 32 15
SPIRIVA 109 86 33 81
ADVAIR DISKUS 108 105 34 58
PREMARIN 107 90 R 35 84
CLONIDINE HCL 104 62 36 38
OXYCODONE HCL-ACETAMINOPHEN 104 21 S2 36 73
AZITHROMYCIN 103 75 38 36
PROAIR HFA 101 82 39 50
ALLOPURINOL 100 65 40 31
CLOPIDOGREL 99 98 41 30
ROPINIROLE HCL 95 62 42 99
METOPROLOL SUCCINATE 94 86 43 18
OXYBUTYNIN CHLORIDE ER 88 71 44 115
FENTANYL 87 77 S2 45 61
RISPERIDONE 86 62 46 49
FLUOXETINE HCL 86 78 46 48
MORPHINE SULFATE ER 83 24 S2 48 41
QUETIAPINE FUMARATE 82 76 49 57
CELEBREX 82 70 49 55
CYCLOBENZAPRINE HCL 80 52 R 51 34
ACTOS 79 45 52 131
PLAVIX 76 75 53 53
DIGOXIN 75 53 54 43
LOSARTAN POTASSIUM 75 74 54 40
ALENDRONATE SODIUM 74 36 56 63
PANTOPRAZOLE SODIUM 73 48 57 72
CARBIDOPA-LEVODOPA 70 50 58 69
TAMSULOSIN HCL 69 60 59 28
FLUTICASONE PROPIONATE 68 54 60 46
PAROXETINE HCL 68 58 60 60
LANTUS 67 45 62 37
RANITIDINE HCL 67 31 62 29
BETAMETHASONE VALERATE 66 58 64 172
GLIPIZIDE 65 51 65 101
METOCLOPRAMIDE HCL 64 39 66 145
GLIPIZIDE ER 63 63 67 123
OLANZAPINE 62 0 68 104
SPIRONOLACTONE 62 34 68 71
AMITRIPTYLINE HCL 62 62 R 68 52
LOSARTAN-HYDROCHLOROTHIAZIDE 61 56 71 74
OXYCODONE HCL 60 0 S2 72 16
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 38 73 70
PROMETHAZINE HCL 58 40 R 73 79
DIVALPROEX SODIUM ER 57 33 75 88
DETROL LA 56 32 76 137
DILTIAZEM ER 53 23 77 151
DIOVAN 52 52 78 109
FAMOTIDINE 51 35 79 79
PROPRANOLOL HCL 51 39 79 113
ENDOCET 50 34 S2 81 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 10, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.